BioCentury
ARTICLE | Clinical News

Belviq XR lorcaserin extended release regulatory update

December 7, 2015 8:00 AM UTC

Eisai and Arena said FDA accepted an NDA for once-daily Belviq XR lorcaserin extended release for chronic weight management. The partners did not disclose the PDUFA date. The product is an extended-re...